- Home
- ZENA vs ATNM Comparison
ZENA vs ATNM Comparison
Compare ZENA & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZENA
- ATNM
- Stock Information
- Founded
- ZENA 2017
- ATNM 2000
- Country
- ZENA Canada
- ATNM United States
- Employees
- ZENA N/A
- ATNM N/A
- Industry
- ZENA
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- ZENA
- ATNM Health Care
- Exchange
- ZENA NYSE
- ATNM Nasdaq
- Market Cap
- ZENA 51.9M
- ATNM 46.5M
- IPO Year
- ZENA N/A
- ATNM N/A
- Fundamental
- Price
- ZENA $2.50
- ATNM $1.38
- Analyst Decision
- ZENA
- ATNM Strong Buy
- Analyst Count
- ZENA 0
- ATNM 4
- Target Price
- ZENA N/A
- ATNM $8.75
- AVG Volume (30 Days)
- ZENA 207.5K
- ATNM 1.2M
- Earning Date
- ZENA 01-01-0001
- ATNM 04-29-2025
- Dividend Yield
- ZENA N/A
- ATNM N/A
- EPS Growth
- ZENA N/A
- ATNM N/A
- EPS
- ZENA N/A
- ATNM N/A
- Revenue
- ZENA $1,364,714.00
- ATNM N/A
- Revenue This Year
- ZENA N/A
- ATNM N/A
- Revenue Next Year
- ZENA N/A
- ATNM N/A
- P/E Ratio
- ZENA N/A
- ATNM N/A
- Revenue Growth
- ZENA 7.43
- ATNM N/A
- 52 Week Low
- ZENA $1.41
- ATNM $1.03
- 52 Week High
- ZENA $12.43
- ATNM $10.24
- Technical
- Relative Strength Index (RSI)
- ZENA N/A
- ATNM 48.76
- Support Level
- ZENA N/A
- ATNM $1.17
- Resistance Level
- ZENA N/A
- ATNM $1.34
- Average True Range (ATR)
- ZENA 0.00
- ATNM 0.13
- MACD
- ZENA 0.00
- ATNM -0.01
- Stochastic Oscillator
- ZENA 0.00
- ATNM 44.00
About ZENA ZENATECH INC
ZenaTech Inc is a enterprise software technology company that specializes in mission-critical cloud-based applications integrated with smart hardware to deliver innovative solutions across diverse industries. The Company operates in software development technology, sales, and distribution. The Company is also developing a drone manufacturing, sales, and distribution business. The company operates in two segments which is software development technology, sales, and distribution, as well as drone manufacturing, sales, and distribution.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.